Maintenance Notice (5:30 - 10:30 PM June 28, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding
Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 99469-99-5 | Product Number: E0928
2-(3-Ethoxy-4-ethoxycarbonylphenyl)acetic Acid
×
![]()
×
Purity: >98.0%(GC)(T)
Synonyms:
- Ethyl 4-Carboxymethyl-2-ethoxybenzoate
- 4-Carboxymethyl-2-ethoxybenzoic Acid Ethyl Ester
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
70,00 €
|
2 | 1 |
|
| 25G |
260,00 €
|
Contact Us | 6 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | E0928 |
| Purity / Analysis Method | >98.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__1__3H__1__6O__5 = 252.27 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 99469-99-5 |
| Reaxys Registry Number | 8210175 |
| PubChem Substance ID | 253659996 |
| MDL Number | MFCD08704233 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Purity(Neutralization titration) | min. 98.0 % |
| Melting point | 78.0 to 82.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 80 °C |
| Solubility (soluble in) | Methanol |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H318 : Causes serious eye damage. |
| Precautionary Statements | P280 : Wear eye protection/ face protection. P305 + P351 + P338 + P310 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. |
Related Laws:
Transport Information:
| HS Number | 2918199890 |
Application
A Synthetic Intermediate of Repaglinide
This product is used for the synthesis of a carbamoylmethyl benzoic acid derivative, repaglinide [R0179] which is a fast-acting insulin-releasing agent used for the treatment of type 2 diabetes.
References
- Repaglinide and Related Hypoglycemic Benzoic Acid Derivatives
- Studies on diastereofacial selectivity of a chiral tert-butanesulfinimines for the preparation of (S)-3-methyl-1-(2-piperidin-1-yl-phenyl)butylamine for the synthesis of repaglinide
- Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.